Description Product Details Viscopaste is a general-purpose first-line treatment for wet and dry leg ulcers. Viscopaste bandages soothe and protect the skin and are easily removed. To augment the treatment, always cover the Viscopaste bandage with a suitable compression bandage. VISCOPASTE PB7 is a 10% w/w zinc paste bandage indicated to assist the management of venous leg ulcers. Where venous insufficiency exists, the paste bandage should be used under graduated compression bandaging.??VISCOPASTE PB7 is also suitable for use in the management of chronic eczema/dermatitis, where occlusion is indicated. Latex Free. Where venous insufficiency exists,??Viscopaste??PB7 may be used under graduated compression bandaging, after first assessing the patient to exclude arterial disease. The use of Doppler ultrasound is recommended for this purpose. Compression bandaging should not be used on patients who have arterial disease (ABPI<0.8) and is not recommended for use on diabetic patients with advanced small vessel disease. Failure to detect reduced arterial flow can result in pressure necrosis, amputation, or even death. The risk of a patient having arterial as well as venous disease rises with age. One of the functions of occlusive bandages is to increase absorption. Care should be taken, therefore, if it is decided to apply topical steroid, anesthetic or retinoid preparations under the bandage, as their absorption may be significantly increased. This may lead to a shorter duration of effect of a topical anesthetic product in addition to increasing the risk of sensitization to these preparations. The skin of leg ulcer patients is easily sensitized to topical medicaments – including preservatives. Sensitization should be suspected in patients, particularly where there is the deterioration of the surrounding skin. Such patients should be referred for a specialist opinion. Indications For the management of leg ulcers. Where venous insufficiency exists, the paste bandage should be adjunct to the graduated compression bandaging. For the management of chronic eczema/dermatitis where occlusion is indicated.
